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This study was designed to isolate the compounds responsible for the cytotoxic properties of South Indian Elephantopus scaber
L. and further investigate their eﬀects on quiescent and proliferating cells. Bioassay-guided isolation of the whole plant of
chloroform extract of South Indian Elephantopus scaber aﬀorded the known sesquiterpene lactone, deoxyelephantopin, and
isodeoxyelephantopin whose structures were determined by spectroscopic methods. These compounds caused a dose dependent
reduction in the viability of L-929 tumour cells in 72h culture (IC50 value of 2.7μg/mL and 3.3μg/mL) by the cell viability assay.
Both the compounds act selectively on quiescent and PHA-stimulated proliferating human lymphocytes and inhibited tritiated
thymidineincorporationintocellularDNAofDLAtumourcells.Thecompounddeoxyelephantopinataconcentrationof3μg/mL
caused maximum apoptotic cells. It also exhibited signiﬁcant in vivo antitumour eﬃcacy against DLA tumour cells. The results,
therefore, indicate that the antiproliferative property of deoxyelephantopin and isodeoxyelephantopin could be used in regimens
for treating tumors with extensive proliferative potencies.
1.Introduction
Plants have served as the major source of medication, for the
treatment of human ailments since time immemorial. Plants
havealonghistoryofuseinthetreatmentofcancer.Thegoal
for the search for new anticancer drugs is to ﬁnd drugs that
act via a speciﬁc mode of action. In this manner, it is hoped
that cancer cells can be targeted with little or no damage
to noncancerous cells. Natural products are perfectly suited
to the current molecular approach of drug development as
they produce few adverse side eﬀects, each inhibits multiple
aspects of cancer cell proliferation and as a group show pro-
pensity for synergistic interaction [1].
Elephantopus scaber L. (Asteraceae) is a genus of herb,
distributed all over the world, especially in America. Of the
32 species, only one species, namely, Elephantopus scaber is
known to grow in India. Studies have shown that several spe-
cies of the genus Elephantopus contain a large number of
cytotoxic and antitumoural sesquiterpene lactones [2–4]and
there is an interest in this plant over the world. Sesquiterpene
lactones are characteristic constituents of the family Astera-
ceae and their principal characteristics are the presence of α,
β-unsaturated γ-lactone [5].
Previous studies from our laboratory have shown that
chloroform extract and the partially puriﬁed fraction of
South Indian E. scaber exhibited cytotoxic as well as antitu-
mour properties [6]. Inspired by the antitumour properties
exhibited by E. scaber, the c hloroform extract was chosen to
isolate the compounds responsible for the cytotoxic proper-
tiesandfurtherinvestigatetheireﬀectsonquiescentandpro-
liferating cells.2 Journal of Biomedicine and Biotechnology
2. Methods
2.1. Experimental. All melting points are uncorrected and
were determined on a Meltemp II hot stage melting point
apparatus. The IR spectra were recorded on Bomem MB
Series FT IR spectrometer. NMR spectra were recorded on
Bruker 300MHz FT NMR spectrometer, using CDCl3 or
CDCl3-CCl4 mixture (7:3) as solvent. TMS was used as
the internal standard and chemical shifts are in δ-scale.
Abbreviations used in 1H NMR are s-singlet, d-doublet, dd-
doublet of a doublet, and m-multiple. Analytical thin lay-
er chromatography was performed on glass plates coated
with silica gel (Merck) containing 13% calcium sulphate as
binder. Column chromatography was done using 100–200
meshsilicagel.Thesolventswereremovedfromthefractions
under reduced pressure using a Buchi rotary evaporator.
2.2. Animals. Swiss albino mice (males) in the age group
of 8–10 weeks, weighing 20–30g, were used for the experi-
ments. The animals were housed under conventional labo-
ratory conditions and fed with standard pellet diet (Lipton
India Ltd., Mumbai, India) and boiled water ad libitum.A l l
experiments involving animals were done, strictly adhering
to the guidelines for animal experimentation and handling,
issued by the Government of India.
2.3. Chemicals. RPMI-1640 medium was obtained from
Gibco BRL, USA, and the antibiotics streptomycin, penicil-
lin, and gentamycin sulphate from Hi-Media Laboratories,
Mumbai. Foetal calf serum, Trypsin, Ethidium bromide,
Acridine Orange, Histopaque, MTT [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide], and vincristine
were obtained from Sigma Chemical Company, USA. Phyto-
haemagglutinin (PHA-M) and Heparin were obtained from
DIFCO, USA. The solvents used for the phytochemical
analyses were LR grade, but except for ﬁnal puriﬁcation and
spectroscopic studies, AR or spectroscopic grade solvents
were used. Silica gel was obtained from Sisco Research Lab-
oratories and Merck Laboratories, Mumbai. Tritiated thymi-
dine was obtained from the Board of Radiation and Isotopes
Technology (BRIT), Mumbai.
2.4. Tumour Cells. Murine ﬁbroblast cell line, L-929 and
Human colon carcinoma cell line, HCT 116 were grown
in RPMI-1640 medium supplemented with 10% FCS,
100U/mL penicillin, 100μg/mL streptomycin, and 50μg/mL
gentamycinsulphate,inahumidiﬁedCO2 incubatorat37◦C.
Daltons Lymphoma Ascitis (DLA) tumours were maintain-
ed as ascites by serial transplantation in mice, by intraperi-
toneal (i.p.) injection of 1 × 106 cells/mouse. The tumor
cells were aspirated from the tumor-bearing mice aseptically
and washed thrice in phosphate-buﬀered saline before trans-
plantation.
2.5. Extraction. Fresh E. scaber plants, collected from TBGRI
campus, Thiruvananthapuram in October 2002, after au-
thentication by the plant taxonomist of the Institute was
deposited in the Herbarium of the institute. The plants were
cleaned and dried under shade for two days and 400g
of the powdered plant material was extracted with hexane
(bp.60◦C) using Soxhlet extractor for 12h. The plant mat-
erial was dried and again extracted with chloroform for 12h.
Theextractswereconcentratedunderreducedpressureusing
rotary evaporator and aﬀorded 9.1g of hexane extract and
5.8g of chloroform extract, respectively.
2.6.PreliminaryPhytochemicalAnalysis. Severalreactionsfor
the identiﬁcation of the chemical constituents present in the
chloroformextractwerecarriedoutbythestandardmethods
of Harborne [7].
2.7. Fractionation of CHCl3 Extract. The CHCl3 extract
(5.8g) wassubjectedto columnchromatographyon silica gel
(60–120 mesh; 200g). The column was eluted with hexane
and gradient of hexane-EtOAc mixture and 50 fractions each
of 100mL were collected. The fractions were pooled accord-
ing to similarities in thin-layer Chromatography (TLC).
2.8. Isolation of Isodeoxyelephantopin. Fraction 16–19
(473mg), eluted with 15% EtOAc in hexane from the above-
mentioned column, was further puriﬁed by column chroma-
tography using silica gel (60–120 mesh, 1.5g). The column
was eluted with hexane and hexane-EtOAc gradient mixture
and 50mL fractions were collected. The fractions eluted
with 10% EtOAc in hexane aﬀorded the pure compound.
2.9. Isolation of Deoxyelephantopin. Fraction 23–26 (425mg)
was puriﬁed by column chromatography using silica gel (60–
120 mesh, 1.5g). Low polar impurities were removed by
eluting the column with 25% EtOAc in hexane and further
elutionwith40%EtOAcinhexaneaﬀordedaUVactivecom-
pound.
2.10. Cytotoxicity Assay Using MTT Method. The in vitro
response of deoxyelephantopin and isodeoxyelephantopin of
E. scaber against L-929 cell line was studied using MTT assay
[8]. L-929 cell line was maintained in RPMI-1640 medium,
supplemented with 10% FCS. Brieﬂy, cells harvested in the
log phase of growth were harvested, counted, and seeded
(4 × 104 cells/well in 500μL volume) in 24-well titre plates.
After 24h of incubation at 37◦Ci n5 %C O 2, to allow cell
attachment, cultures were treated with varying concentra-
tions of drugs (2–10μg/mL) diluted with medium. Vehicle
controls were also kept, that is, DMSO at concentrations not
exceeding 1%. The plates were further incubated for 48h.
On completion of incubation, with the drugs, the plates were
removed and to each well 20μL of a 5mg/mL stock solution
of MTT were added and the plates were further incubated
for 4h. Then, the supernatant from each well was carefully
removed and the MTT-formazan crystals were dissolved in
100μL 100% DMSO and the absorbance at 570nm was
measured, using a spectrophotometer. Three replicate wells
were set up for each experiment. For each drug, the con-
centration required to reduce absorbance by 50% (IC50)i n
comparisontocontrolcellswasdetermined.IC50 valueswere
derived by substituting the percentage inhibition values ofJournal of Biomedicine and Biotechnology 3
the drugs against the doses used. % growth inhibition =
100 − [(absorbance of the drug treated cells/absorbance of
the untreated control cells) × 100%].
2.11. Eﬀect of Deoxyelephantopin and Isodeoxyelephantopin
on Quiescent and PHA-Stimulated Proliferating Human
Lymphocytes
2.11.1. Lymphocyte Isolation. For culturing human periph-
eral blood lymphocytes, venous blood from healthy human
volunteers was collected in heparinized tubes. Lymphocytes
were separated from polymorphonuclear leukocytes and
erythrocytes by Histopaque gradient method. The blood was
diluted with 1:3 volume of PBS and layered onto 1mL of
Histopaque and centrifuged at 2,000rpm for 20min at room
temperature. Lymphocytes were aspirated from the gradient
plasma interfaces and washed twice in PBS and the ﬁnal cell
pellets were resuspended in RPMI-1640 medium containing
10% FCS, 100μL penicillin, 100μL streptomycin, and 100μL
fungicide (pH 7.4). Viability of the cells was checked by
staining with 0.1% trypan blue.
2.11.2. Lymphocyte Proliferation Assay. Brieﬂy, 200μLo f
isolated lymphocytes (1 × 106/well) were seeded on 24-well
titre plates and grown in 10% FCS containing RPMI-1640
medium at 37◦Ci n5 %C O 2 in a humidiﬁed chamber. The
cells were stimulated with 10μLP H A( 5μg/mL) and wells
without PHA served as positive control. To study the lym-
phocyte proliferation, in the absence of mitogen PHA, 10μL
of PHA was replaced by medium and served as negative con-
trol. Both PHA-stimulated and unstimulated lymphocytes
were treated with varying concentrations of deoxyelephanto-
pin and isodeoxyelephantopin (2–10μg/mL) for 72h. 18h
prior to termination, 2μCi/mL [3H] thymidine was added.
The cells were then harvested using cell harvester and
the radioactivity was measured using liquid scintillation
counter. From the counts obtained (CPM), the percentage
inhibition in thymidine incorporation was calculated. The
percentage of incorporation was calculated as follows: %
incorporation = [(CPM of treated group/CPM of control
group)] × 100 % inhibition incorporation = 100 − %
incorporation.
2.12. Eﬀect of Deoxyelephantopin and Isodeoxyelephantopin
on DNA Synthesis. Thymidine labelling technique was used
to evaluate DNA synthesis of Dalton’s ascitic tumour cells
(DLA) following drug treatment. Incorporation of tritiated
thymidine into DNA was done by incubating DLA cells
(1 × 106)w i t h2μCi/mL of [3H] labelled thymidine in the
presence of various concentrations of drugs (2–10μg/mL)
in 2mL RPMI-1640 medium containing 10% FCS at 37◦C
and 5% CO2 atmosphere for 4h. Control tubes were main-
tained without drugs. After incubation, the DNA was pre-
cipitated with 0.8N perchloric acid and redissolved in
0.5mL of NaOH (0.5M) and cells harvested onto glass ﬁber
discs, using a PHD cell harvester (Cambridge technology,
Cambridge, MA). The glass ﬁber discs were counted in vials
containing 3mL scintillation-counting mixture, in a Wal-
lac1410 β-liquid scintillation counter. From the counts
obtained (CPM), the percentage inhibition in thymidine in-
corporation was calculated.
2.13. Morphological Analysis of Apoptotic Cells
2.13.1. Analysis of DLA Cell Death (Apoptosis) Using Fluores-
cence Microscopy. Cells were cultured in 24-well titre plates.
1×106 DLAcellswereincubatedinRPMI1640mediumwith
5% FCS containing various concentrations (1–10μg/mL) of
deoxyelephantopin in a CO2 incubator at 37◦Cf o r6ha n d
18h. For assessment of apoptosis, 6h and 18h after exposure
to diﬀerent concentrations of drug treatment, acridine
orange-ethidium bromide dual staining of unﬁxed DLA cells
was used. These dyes stain the DNA and allow visualization
of the condensed chromatin of apoptotic cells. The medium
was removed, cells pelleted gently, and 1μL of acridine
orange (100μg/mL) + ethidium bromide (100μg/mL) in
1mL PBS was added to cells and immediately washed once
with phosphate buﬀer saline (PBS) and resuspended in
10μL of 10% glycerol in PBS and the slides analyzed by ﬂu-
orescence microscopy (Nikon Diaphot, UV 410). The num-
ber of cells manifesting morphologic features of apoptosis
such as chromatin condensation and loss of nuclear envelope
[9]wascountedasafunctionofthetotalnumberofcellspre-
sentintheﬁeld.Forcelldeathevaluation,threesampleswere
prepared for each experimental point and the experiment
was repeated three times.
2.13.2. Analysis of HCT 116 Cell Death (Apoptosis) Using Flu-
orescence Microscopy. 2 × 104/well HCT 116 human colon
cancercelllinewasseededintoeachwellof24titre-wellplas-
tic culture plate containing 12mm cover slip. After 24h, the
cells were incubated with varying concentrations of deoxy-
elephantopin (1–10μg/mL). After 48h, the cover slip was
carefully removed from the medium and washed twice with
PBS and 1μL of acridine orange (100μg/mL) + ethidium
bromide (100μg/mL) in 1mL PBS was added to cells. The
cellswereimmediatelywashedoncewithPBSandsuspended
in 10μL of 10% glycerol in PBS and viewed under ﬂuor-
escence microscopy (Nikon Diaphot, UV 410) and apoptosis
evaluated.
2.14. Eﬀect of Deoxyelephantopin on the Ascitic Tumour Re-
duction in Mice. The antitumour activity of deoxyelephan-
topin was determined, as described previously [10]. Brieﬂy,
Swissalbinomice(20–25mg)werechallengedwithDLAcells
(1×106 cells)anddividedinto5groupsof10each.After24h,
animals of group I serving as control were given 0.5mL of
10% DMSO. The group II, III, and IV received the deoxyele-
phantopin 25mg, 50mg, and 100mg/kg, b.w., i.p, respec-
tively, and group V received vincristine (1mg/kg b.w, i.p).
Vincristine was used as a standard anticancer agent for com-
parison. The administration of deoxyelephantopin and vin-
cristine was continued intraperitoneally for 15 days. Growth
inhibitoryeﬀectofDLAtumourcellsimplantedintotheper-
itoneal cavity was evaluated by determination of animal sur-
vival, recorded and expressed as mean survival time (MST)4 Journal of Biomedicine and Biotechnology
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Figure 1: (a) Structure of isodeoxyelephantopin, (b) structure of deoxyelephantopin.
in days, and the percentage increase in life span % ILS) of
drug treated group was determined.
2.15. Statistical Analysis. Experimental data were expressed
as mean ± S.D. Student’s “t” test was applied for expressing
the signiﬁcance and P value less than 0.05 was considered as
signiﬁcant.
3. Result
The preliminary phytochemical analysis of the chloroform
extract revealed the presence of terpenes, ﬂavonoids, coum-
arins, and alkaloids.
The extract upon fractionation using column chromato-
graphy and further puriﬁcation by rechromatography yield-
ed two UV active sesquiterpene dilactones viz: isodeoxyele-
phantopin and deoxyelephantopin. Isodeoxyelephantopin
(90mg) was crystallized from petroleum ether- EtOAc mix-
ture as colourless needles (mp. 151–153◦C, Lit.150–153◦C).
3.1. Isodeoxyelephantopin. IR (cm−1): 3075, 2968, 2935,
1765, 1750, 1714, 1638, 1444, 1320, 1155, 983, 951, 886, 815.
1H NMR: 7.16 (s, 1H), 6.20 (d, 1H, J = 3.7Hz), 6.15 (s,
1H), 5.68 (s, 1H), 5.65 (d, 1H, J = 3.3Hz), 5.38 (d, 1H, J =
3.9Hz), 5.21–5.10 (m, 2H), 4.55–4.49 (m, 1H), 3.17–2. (m,
3H), 2.75 (dd, 1H, J = 3.6Hz, 12.6Hz), 1.93 (s, 3H), 1.79
(s, 3H).
13C NMR: 174.4, 169.5, 166.6, 149.5, 135.5, 135.5, 134.1,
131.5, 126.9, 125.4, 123.2, 79.5, 78.8, 74.1, 49.9, 40.1, 30.1,
21.6, 18.2.
From the data, the structure of the compound was
assigned as isodeoxyelephantopin (Figure 1(a)). The struc-
ture was conﬁrmed by the spectral data and melting point of
the compound [11, 12].
Puriﬁcation of another pool of chloroform fractions by
repeated chromatography aﬀorded another UV active ses-
quiterpenedilactone,deoxyelephantopin(80mg).Thiscom-
poundwascrystallizedfrompetroleumether-EtOAcmixture
as colourless needles (mp. 199–200◦C, Lit. 196–199◦C).
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Figure 2: Percentage inhibition of deoxyelephantopin and isodeox-
yelephantopin against L-929 tumour cell line using MTT assay.
3.2. Deoxyelephantopin. IR (cm−1): 3100, 2962, 1751, 1770,
1707, 1632, 1432, 1295, 1201 1170, 927.
1H NMR: 7.11 (s, 1H), 6.22 (d, 1H, J = 3.5Hz), 6.14 (s,
1H), 5.65 (m, 2H), 5.46 (d, 1H, J =1.7Hz), 5.14 (dd, 1H,
J = 8.2Hz, 10.2Hz), 4.78 (d, 1H, J = 10.3Hz), 4.65 (m, 1H),
3.03–2.68 (m, 5H), 1.93 (s, 3H), 1.84 (s, 3H).
13CNMR: 172.4, 169.3, 166.3, 153.3, 135.9, 135.6, 134.1,
133.7, 128.5, 81.3, 77.9, 71.5, 52.3, 41.3, 33.5, 20.1, 18.2.
From the data, the structure was assigned as deoxyele-
phantopin (Figure 1(b)). The structure was conﬁrmed by
comparing the spectral values and melting point of the com-
pound (13, 12).
3.3. Cytotoxicity Using L-929 Tumour Cell Line. The deoxyel-
ephantopin and isodeoxyelephantopin showed a dose-de-
pendent cytotoxicity to L-929 cell line in culture. The ses-
quiterpene lactones, deoxyelephantopin, and isodeoxyele-
phantopin exhibited maximum cytotoxicity, having an IC50
value of 2.7μg/mL and 3.3μg/mL, respectively (Figure 2).
3.4. Lymphocyte Proliferation. To ascertain whether deoxyel-
ephantopin and isodeoxyelephantopin speciﬁcally inhibit
the proliferation of dividing cells, their eﬀect was assessed
on unstimulated and PHA-stimulated human lymphocytesJournal of Biomedicine and Biotechnology 5
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Figure 3: Inﬂuence of deoxyelephantopin and isodeoxyelephan-
topin on proliferative responses to the PHA-stimulation of normal
lymphocytes. Values are ± SD of three replicates of three indepen-
dent experiments, ∗∗∗P<0.001.
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Figure 4: Inﬂuence of the deoxyelephantopin and isodeoxyele-
phantopin on proliferative responses in absence of mitogen PHA.
Values are ± SD of three replicates of three independent experi-
ments, ∗∗∗P<0.001.
in culture. Deoxyelephantopin and isodeoxyelephantopin
signiﬁcantly decreased the [3H] thymidine incorporation of
proliferating (PHA-stimulated) lymphocytes in a dose-de-
pendent manner, when compared to the positive control
(Figure 3). However, there was no signiﬁcant change in the
proliferationofunstimulatedlymphocytesexposedtodeoxy-
elephantopin and isodeoxyelephantopin (Figure 4).
3.5. Inhibition of DNA Synthesis. DLA cells treated both
with deoxyelephantopin and isodeoxyelephantopin showed
decreased [3H] thymidine incorporation into the nuclear
DNA, suggesting that they inhibited DNA synthesis. The
results on DNA synthesis also indicated a concentration-de-
pendent decrease in [3H] thymidine incorporation
(Figure 5). The concentration of deoxyelephantopin and
isodeoxyelephantopin required to produce 50% in-incorpo-
ration was 2.2μg/mL and 2.9μg/mL, respectively (Figure 6).
3.6. Morphological Analysis of Apoptotic Cells. The percent-
ages of viable and nonviable (apoptotic) DLA cells after in
vitro exposure to various concentrations of deoxyelephanto-
pinwithacridineorangeandethidiumbromidestainingdur-
ing 6h and 18h treatment period are presented in Table 1.
DLA cells exposed to 2μg/mL deoxyelephantopin showed
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Figure 5: Eﬀect of deoxyelephantopin and isodeoxyelephantopin
on DNA synthesis of DLA tumour cells. Values are ± SD of three
replicates of three independent experiments, ∗∗∗P<0.001.
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Figure 6: Eﬀect of deoxyelephantopin and isodeoxyelephantopin
on percentage inhibition of DNA synthesis of DLA tumour cells.
reductioninthepercentageofviablecells,butthecellsexpos-
ed to 3μg/mL of deoxyelephantopin exhibited a signiﬁcant
reduction in the percentage of viable cells (52.63% and
70.65%), compared to the control group during 6h and 18h
treatment period, respectively. The higher concentrations of
drug such as 8μg/mL and 10μg/mL showed necrosis, which
is characterized by swelling of cytoplasm and organelles,
whichareassociatedwithmembranelysis,insteadofapopto-
sis. The proportion of apoptotic cells was higher during 18h
treatment period.
During 48h treatment period, HCT-116 colon cancer
cell line stained with ethidium bromide and acridine orange
exhibited a signiﬁcant reduction in the percentage of viable
cells (77.08%) and increase in percentage of apoptotic cells
when exposed to 3μg/mL deoxyelephantopin compared
to the control group (Table 2). Deoxyelephantopin caused
shrinkage after 24h in HCT-116 cells and the shrinkage
was prominent after 48h duration of exposure due to
cytoplasmic condensation, where most of the cells rounded
up (dead cells).
3.7. Eﬀect of Deoxyelephantopin on the Ascitic Tumour Reduc-
tion in Mice. The deoxyelephantopin exhibited remarkable
antitumour activity. Administration of deoxyelephantopin
(50mg/kg, b.w and 100mg/kg b.w) signiﬁcantly reduced
murine ascitic tumour growth and increased the life span
of DLA tumour-bearing mice by 67.64% and 72.51%,6 Journal of Biomedicine and Biotechnology
Table 1: Apoptosis (percentage of cells) of DLA cells treated with deoxyelephantopin as determined by microscopic morphological observa-
tion, stained with acridine orange and ethidium bromide.
Con. of deoxyelephantopin
(μg/mL)
Treatment time (6h) Treatment time (18h)
Percentage of cellsx (%) Percentage of cellsx (%)
Viable cells Non-viable cells Viable cells Non-viable cells
Apoptotic Necrotic Apoptotic Necrotic
0 (control) 95 ±4.2— 5 ±0.25 92 ±4.52 ±0.28 6 ±0.49
1 68 ±3.82 6 ±1.71 6 ±0.40 61 ±4.02 30 ±2.15 9 ±0.56
3 45 ±2.15 39 ±2.79
∗∗∗ 16 ±1.72 27 ±1.93 46 ±3.29
∗∗∗ 27 ± 1.85
6 29 ±1.78 30 ±1.68 41 ±2.56 20 ±1.37 35 ±2.44 5 ± 4.04
8 15 ±0.87 9 ±0.52 76 ±5.22 13 ±1.17 5 ±0.45 82 ± 5.12
10 12 ±0.67 9 ±0.55 79 ±4.86 10 ±0.90 6 ±0.37 84 ± 7.55
xcells (viable + nonviable) = 100%, ∗∗∗P<0.001 compared to control.
Table 2: Apoptosis (percentage of cells) of HCT-116 colon cancer cells treated with deoxyelephantopin as determined by microscopic mor-
phological observation, stained with acridine orange and ethidium bromide.
Con.of deoxy elephantopin
(μg/mL)
Treatment time (24h) Treatment time (48h)
Percentage of cellsx (%) Percentage of cellsx (%)
Viable cells Non-viable cells Viable cells Non-viable cells
Apoptotic Necrotic Apoptotic Necrotic
0 (control) 97 ± 4.4—3 ±0.25 96 ± 4.62 ±0.15 1 ±0.10
1 59 ±4.33 28 ±2.11 13 ±0.87 55 ±2.79 31 ±2.11 4 ± 0.97
3 30 ± 1.63 9 ±2.6
∗∗∗ 31 ±2.79 22 ±1.52 42 ±2.5
∗∗∗ 36 ± 1.98
6 20 ±1.51 32 ±2.41 48 ±3.25 18 ±1.24 30 ±1.95 2 ± 3.59
8 13 ±0.35 6 ±0.44 81 ±4.11 12 ±0.81 4 ±0.28 84 ± 4.27
10 9 ±0.60 7 ±0.47 84 ± 5.8
∗∗∗ 9 ±0.46 4 ±0.26 87 ±5.5
xcells (viable + nonviable) = 100%, ∗∗∗P<0.001 compared to control.
respectively (Table 3). The higher dose of deoxyelephantopin
(100mg/kg, b.w, i.p) was found to be very eﬀective when
compared to the other two doses and aﬀorded the protection
of 6 animals out of 10 DLA-challenged mice. In the case of
control animals treated with DMSO, the tumour grew pro-
gressively and the survival time was signiﬁcantly reduced.
The results were comparable with those of standard antican-
cer drug, vincristine.
4. Discussion
The MTT cell viability assay is widely used in determining
drugsensitivityinprimaryscreeningofpotentialchemother-
apeutic drugs. The isolated pure compounds belonging to
the class of sesquiterpene lactones, deoxyelephantopin, and
isodeoxyelephantopin caused a signiﬁcant dose-dependent
reduction in the viability of L-929 tumour cells in 72h
culture. The structural diﬀerence between deoxyelephanto-
pin and isodeoxyelephantopin is that γ-lactone ring oxygen
atom at C-2 is β-oriented in deoxyelephantopin whereas is
α-oriented in deoxyelephantopin. Kupchan et al. [13]h a v e
shown that the presence of C11-C13 exocyclic double bond
conjugated to the γ-lactone function which can undergo
a Michael addition is essential for cytotoxicity. Sesquit-
erpene which incorporated a cyclopentenone or a methylene
lactone (in addition to the α, β methylene-γ lactone)
appeared to produce enhanced cytotoxicity. The success of
deoxyelephantopin and isodeoxyelephantopin that possess
C11-C13 exocyclic methylene conjugated to γ-lactone, to ex-
hibit signiﬁcant cytotoxicity to tumour cell line, is in agree-
ment with these suggestions. These ﬁndings are in agree-
ment with the studies of sesquiterpene lactones, helena-
in possessing both the reactive α-methylene-γ-lactone moi-
ety, and a reactive α, β-unsubstituted cyclopentenone ring,
displaying thestrongestcytotoxicityagainsttumourcelllines
using MTT assay [14].
Lymphocyte proliferation in vitro is usually determined
by measuring [3H] thymidine uptake by nuclear DNA after
72h of culture. Mitogen stimulated cells commence DNA
synthesis approximately 24h after mitogen addition. Max-
imum thymidine incorporation occurs during 60–72h time
period and thus 72h culture has been selected in the present
study. The compounds, deoxyelephantopin and isodeoxyele-
phantopin, failed to augment human T-lymphocyte prolifer-
ation, induced by T-mitogen PHA as evidenced by decreased
[3H] thymidine uptake by nuclear DNA. Quiescent lympho-
cytes were refractory to the action of deoxyelephantopin and
isodeoxyelephantopin.
IthasbeenreportedthatcleistanthinA,adiphyllinglyco-
side from Cleistanthus collinus possessing cytotoxic and
tumour regressing properties, was cytotoxic to PHA-stimu-
lated proliferating human lymphocytes [15]. The eﬀects ofJournal of Biomedicine and Biotechnology 7
Table 3: Eﬀect of intraperitoneal administration of deoxyelephantopin on the life span of DLA-tumour-bearing mice.
Treatments
Number of mice survived after tumour inoculation (days) Mean survival
time (days) Life span (%) Increase in
life span (%) 15 25 35
Group I DLA
(Control) 10/10 5/10 0/10 22.56 ±2.57 100 —
Group II
DLA + Deoxy-
elephantopin
(25mg/kg, i.p)
10/10 6/10 3/10 30.90 ±3.36 136.96 36.96
Group III
DLA + Deoxy-
elephantopin
(50mg/kg, i.p)
10/10 8/10 5/10 37.82 ±3.70 167.64 67.64
Group IV
DLA + Deoxy-
elephantopin
(100mg/kg, i.p)
10/10 8/10 6/10 38.92 ±3.5
∗∗∗ 172.51 72.51
Group V
DLA +
Vincristine
(1mg/kg, i.p)
10/10 10/10 6/10 43.54 ±3.9 192.99 92.99
Values are mean ± SD of three experiments, n = 10, ∗∗∗P<0.001 compared to control (the time period required for the death of all the animals in the con-
trol group was 22).
resveratrol on the G0-G1 transition and cell cycle progres-
sion of mitogenically stimulated human lymphocytes have
cancer-preventive properties [16] .Ac o m p o u n di sj u d g e da s
a good anticancer drug, when it is more speciﬁc towards
tumour cells in comparison to normal cells. The results
of the present study indicate that the sesquiterpene lac-
tones, deoxyelephantopin, and isodeoxyelephantopin are not
cytotoxic to normal human lymphocytes and only the pro-
l i f e r a t i n gc e l l sw e r ea ﬀected.
The site of action of a drug can be evaluated by [3H]
thymidine incorporation studies. The [3H] thymidine incor-
poration studies revealed that the deoxyelephantopin and
isodeoxyelephantopin inhibited DNA synthesis as seen by
decreased incorporation of thymidine. The incorporation of
[3H] thymidine into DNA was high in the control than the
drug-treatedcultures.ThegrowthofDLAtumourcellsisdue
to uncontrolled cell division and the basic fact underlying
this phenomenon should be enhanced DNA synthesis. Anti-
cancer drugs exercise their eﬀects through a variety of mech-
anism of action. It may inhibit stages/stages in the multi-
plication of DNA and/or in the synthesis of proteins. Since
DNA synthesis was inhibited, it meant the compounds
exertedcytotoxiceﬀectontumourcells.Theradioactivityin-
corporated is inversely proportional to the concentration
of the drug used. The rate of incorporation depends on
the type of plant drug, the concentration of radioactive
compound, and the type of cells used. Thus, [3H] thymidine
incorporation studies indicate the possible mechanism of
action of deoxyelephantopin and isodeoxyelephantopin used
at the DNA level. These ﬁndings are in agreement with the
studies of sesquiterpene lactones with the exocyclic methy-
lene groups from Helianthus annuus that play an impor-
tant role in triggering the inhibitory eﬀect of DNA and RNA
synthesis as evident by measuring 14C-labelled thymidine,
uridine, and leucine incorporated into murine cells of the
ascitic Ehrlich carcinoma (EAC) [17].
Analysis of cell death (apoptosis) using ﬂuorescence
microscopy indicates that maximum apoptotic cells were ob-
tained at a concentration of 3μg/mL of deoxyelephantopin
that can be considered as optimum dose for inducing apop-
tosis both in DLA cells and HCT-116 cancer cells. The cyto-
toxic sesquiterpene lactones mediate their death-inducing
eﬀect in leukaemia T cells by triggering apoptosis [18].
The involvement of apoptosis is one of the mechanisms of
cell death, induced by clinically relevant chemotherapeutic
drugs in human leukemic T-lymphocytes [19]. Hence, in
the present study, it is possible to conﬁrm apoptosis as one
of the methods of antitumour activity, since results of the
study indicate that deoxyelephantopin, a sesquiterpene lac-
tone isolated from E. scaber induces apoptosis in DLA
tumour cells and HCT-116 colon cancer cells.
The deoxyelephantopin administered after DLA trans-
plantation reduced the ascitic tumour growth as evidenced
from percentage increase of life span of treated mice. This
indicated the cytotoxic eﬀect of deoxyelephantopin on tum-
our cells and its in vivo eﬃcacy against DLA tumour cells
is equal to vincristine (1mg/kg, b.w). Although deoxyele-
phantopin (25mg/kg, i.p.) evoked antitumour response in
vivo, signiﬁcant antitumoureﬀect was noted with higher
dosesofdeoxyelepantopin (50mg/kg,i.pand100mg/kg,i.p)
exhibiting no toxic eﬀects. Increase in life span is a reliable
criterionforjudgingthevalueofanyanticancerdrug.Hence,
the increase in life span of DLA tumour-bearing mice by
treatment with deoxyelephantopin is a positive ﬁnding and
supports the antitumour eﬀect of the drug.8 Journal of Biomedicine and Biotechnology
Our results, therefore, indicate that the antiproliferative
property of deoxyelephantopin and isodeoxyelephantopin
could be used in regimens for treating tumors with extensive
proliferative potencies.
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